1 |
51882
|
miriam.bag
|
<RESOURCE_PROFILE>
|
2 |
|
|
<HEADER>
|
3 |
58272
|
alessia.ba
|
<RESOURCE_IDENTIFIER value="9f272aa2-a141-4a4a-8777-b2e4116a14db_Q29udGV4dERTUmVzb3VyY2VzL0NvbnRleHREU1Jlc291cmNlVHlwZQ=="/>
|
4 |
51882
|
miriam.bag
|
<RESOURCE_TYPE value="ContextDSResourceType"/>
|
5 |
|
|
<RESOURCE_KIND value="ContextDSResources"/>
|
6 |
|
|
<RESOURCE_URI value=""/>
|
7 |
58312
|
alessia.ba
|
<DATE_OF_CREATION value="2020-03-16T13:00:00+00:00"/>
|
8 |
51882
|
miriam.bag
|
</HEADER>
|
9 |
|
|
<BODY>
|
10 |
|
|
<CONFIGURATION>
|
11 |
58312
|
alessia.ba
|
<context id="covid-19" label="COVID-19" type="community">
|
12 |
|
|
<param name="status">all</param>
|
13 |
58272
|
alessia.ba
|
<param name="description">The scope of this community is to provide access to publications, research data, projects and software that may be relevant to the Corona Virus Disease (COVID-19). </param>
|
14 |
|
|
<param name="logourl">https://commons.wikimedia.org/wiki/File:2019-nCoV-CDC-23312_without_background.png#/media/File:2019-nCoV-CDC-23312_without_background.png</param>
|
15 |
|
|
<param name="name">COVID-19</param>
|
16 |
58312
|
alessia.ba
|
<param name="manager">emma.lazzeri@isti.cnr.it,paolo.manghi@isti.cnr.it,noad-it@openaire.eu</param>
|
17 |
|
|
<param name="subject">COVID-19,SARS-CoV-2,2019-nCoV,Severe acute respiratory syndrome coronavirus 2,2019 novel coronavirus,coronavirus disease 2019,coronavirus disease-19,HCoV-19,mesh:COVID-19,mesh:C000657245</param>
|
18 |
58272
|
alessia.ba
|
<param name="suggestedAcknowledgement"></param>
|
19 |
|
|
<param name="zenodoCommunity">covid-19</param>
|
20 |
|
|
<param name="creationdate">2020-03-16T13:00:00</param>
|
21 |
58312
|
alessia.ba
|
<category claim="false" id="covid-19::projects" label="covid-19 Projects">
|
22 |
58510
|
alessia.ba
|
<concept claim="false" id="covid-19::projects::1" label="I-MOVE-COVID-19">
|
23 |
|
|
<param name="projectfullname">Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic</param>
|
24 |
|
|
<param name="CD_PROJECT_NUMBER">101003673</param>
|
25 |
|
|
<param name="funding">EC | H2020 | RIA</param>
|
26 |
|
|
<param name="funder">EC</param>
|
27 |
|
|
<param name="acronym">I-MOVE-COVID-19</param>
|
28 |
|
|
</concept>
|
29 |
|
|
<concept claim="false" id="covid-19::projects::2" label="RECoVER">
|
30 |
|
|
<param name="projectfullname">Rapid European COVID-19 Emergency research Response</param>
|
31 |
|
|
<param name="CD_PROJECT_NUMBER">101003589</param>
|
32 |
|
|
<param name="funding">EC | H2020 | RIA</param>
|
33 |
|
|
<param name="funder">EC</param>
|
34 |
|
|
<param name="acronym">RECoVER</param>
|
35 |
|
|
</concept>
|
36 |
|
|
<concept claim="false" id="covid-19::projects::3" label="HERoS">
|
37 |
|
|
<param name="projectfullname">Health Emergency Response in Interconnected Systems</param>
|
38 |
|
|
<param name="CD_PROJECT_NUMBER">101003606</param>
|
39 |
|
|
<param name="funding">EC | H2020 | RIA</param>
|
40 |
|
|
<param name="funder">EC</param>
|
41 |
|
|
<param name="acronym">HERoS</param>
|
42 |
|
|
</concept>
|
43 |
|
|
<concept claim="false" id="covid-19::projects::4" label="EpiPose">
|
44 |
|
|
<param name="projectfullname">Epidemic intelligence to minimize 2019-nCoV’s public health, economic and social impact in Europe</param>
|
45 |
|
|
<param name="CD_PROJECT_NUMBER">101003688</param>
|
46 |
|
|
<param name="funding">EC | H2020 | RIA</param>
|
47 |
|
|
<param name="funder">EC</param>
|
48 |
|
|
<param name="acronym">EpiPose</param>
|
49 |
|
|
</concept>
|
50 |
|
|
<concept claim="false" id="covid-19::projects::5" label="RiPCoN">
|
51 |
|
|
<param name="projectfullname">Rapid interaction profiling of 2019-nCoV for network-based deep drug-repurpose learning (DDRL)</param>
|
52 |
|
|
<param name="CD_PROJECT_NUMBER">101003633</param>
|
53 |
|
|
<param name="funding">EC | H2020 | RIA</param>
|
54 |
|
|
<param name="funder">EC</param>
|
55 |
|
|
<param name="acronym">RiPCoN</param>
|
56 |
|
|
</concept>
|
57 |
|
|
<concept claim="false" id="covid-19::projects::6" label="CoNVat">
|
58 |
|
|
<param name="projectfullname">Combating 2019-nCoV: Advanced Nanobiosensing platforms for POC global diagnostics and surveillance</param>
|
59 |
|
|
<param name="CD_PROJECT_NUMBER">101003544</param>
|
60 |
|
|
<param name="funding">EC | H2020 | RIA</param>
|
61 |
|
|
<param name="funder">EC</param>
|
62 |
|
|
<param name="acronym">CoNVat</param>
|
63 |
|
|
</concept>
|
64 |
|
|
<concept claim="false" id="covid-19::projects::7" label="CoronaDX">
|
65 |
|
|
<param name="projectfullname">Three Rapid Diagnostic tests (Point-of-Care) for COVID-19 CoronaThree Rapid Diagnostic tests (Point-of-Care) for Coronavirus, improving epidemic preparedness, public health and socio-economic benefits</param>
|
66 |
|
|
<param name="CD_PROJECT_NUMBER">101003562</param>
|
67 |
|
|
<param name="funding">EC | H2020 | RIA</param>
|
68 |
|
|
<param name="funder">EC</param>
|
69 |
|
|
<param name="acronym">CoronaDX</param>
|
70 |
|
|
</concept>
|
71 |
|
|
<concept claim="false" id="covid-19::projects::8" label="Fight-nCoV ">
|
72 |
|
|
<param name="projectfullname">FIGHTING-OFF CORONAVIRUS (SARS-CoV-2) WITH BROAD-SPECTRUM ANTIVIRALS: ESTABLISHING ANIMAL VIRAL CHALLENGE MODEL</param>
|
73 |
|
|
<param name="CD_PROJECT_NUMBER">101003555</param>
|
74 |
|
|
<param name="funding">EC | H2020 | RIA</param>
|
75 |
|
|
<param name="funder">EC</param>
|
76 |
|
|
<param name="acronym">Fight-nCoV</param>
|
77 |
|
|
</concept>
|
78 |
|
|
<concept claim="false" id="covid-19::projects::9" label="SCORE">
|
79 |
|
|
<param name="projectfullname">Swift COronavirus therapeutics REsponse</param>
|
80 |
|
|
<param name="CD_PROJECT_NUMBER">101003627</param>
|
81 |
|
|
<param name="funding">EC | H2020 | RIA</param>
|
82 |
|
|
<param name="funder">EC</param>
|
83 |
|
|
<param name="acronym">SCORE</param>
|
84 |
|
|
</concept>
|
85 |
|
|
<concept claim="false" id="covid-19::projects::10" label="Solnatide">
|
86 |
|
|
<param name="projectfullname">Exploration of safety, tolerability and clinical efficacy of Solnatide IMP in patients infected with the 2019 new coronavirus</param>
|
87 |
|
|
<param name="CD_PROJECT_NUMBER">101003595</param>
|
88 |
|
|
<param name="funding">EC | H2020 | RIA</param>
|
89 |
|
|
<param name="funder">EC</param>
|
90 |
|
|
<param name="acronym">Solnatide</param>
|
91 |
|
|
</concept>
|
92 |
|
|
<concept claim="false" id="covid-19::projects::11" label="ATAC">
|
93 |
|
|
<param name="projectfullname">Antibody therapy against coronavirus (COVID-19)</param>
|
94 |
|
|
<param name="CD_PROJECT_NUMBER">101003650</param>
|
95 |
|
|
<param name="funding">EC | H2020 | RIA</param>
|
96 |
|
|
<param name="funder">EC</param>
|
97 |
|
|
<param name="acronym">ATAC</param>
|
98 |
|
|
</concept>
|
99 |
|
|
<concept claim="false" id="covid-19::projects::12" label="MANCO">
|
100 |
|
|
<param name="projectfullname">Monoclonal Antibodies against 2019-New Coronavirus</param>
|
101 |
|
|
<param name="CD_PROJECT_NUMBER">101003651</param>
|
102 |
|
|
<param name="funding">EC | H2020 | RIA</param>
|
103 |
|
|
<param name="funder">EC</param>
|
104 |
|
|
<param name="acronym">MANCO</param>
|
105 |
|
|
</concept>
|
106 |
|
|
<concept claim="false" id="covid-19::projects::13" label="CoroNAb">
|
107 |
|
|
<param name="projectfullname">Nanobodies and antibodies against 2019-nCoV</param>
|
108 |
|
|
<param name="CD_PROJECT_NUMBER">101003653</param>
|
109 |
|
|
<param name="funding">EC | H2020 | RIA</param>
|
110 |
|
|
<param name="funder">EC</param>
|
111 |
|
|
<param name="acronym">CoroNAb</param>
|
112 |
|
|
</concept>
|
113 |
|
|
<concept claim="false" id="covid-19::projects::14" label="OPENCORONA">
|
114 |
|
|
<param name="projectfullname">Rapid therapy development through Open nCoronavirus Vaccine Platform</param>
|
115 |
|
|
<param name="CD_PROJECT_NUMBER">101003666</param>
|
116 |
|
|
<param name="funding">EC | H2020 | RIA</param>
|
117 |
|
|
<param name="funder">EC</param>
|
118 |
|
|
<param name="acronym">OPENCORONA</param>
|
119 |
|
|
</concept>
|
120 |
|
|
<concept claim="false" id="covid-19::projects::15" label="Prevent-nCoV">
|
121 |
|
|
<param name="projectfullname">Prevention of SARS-CoV-2 infection through development and clinical testing of a novel Virus Like Particle (VLP) vaccine</param>
|
122 |
|
|
<param name="CD_PROJECT_NUMBER">101003608</param>
|
123 |
|
|
<param name="funding">EC | H2020 | RIA</param>
|
124 |
|
|
<param name="funder">EC</param>
|
125 |
|
|
<param name="acronym">Prevent-nCoV</param>
|
126 |
|
|
</concept>
|
127 |
|
|
<concept claim="false" id="covid-19::projects::16" label="EXSCALATE4CoV">
|
128 |
|
|
<param name="projectfullname">EXaSCale smArt pLatform Against paThogEns for Corona Virus</param>
|
129 |
|
|
<param name="CD_PROJECT_NUMBER">101003551</param>
|
130 |
|
|
<param name="funding">EC | H2020 | RIA</param>
|
131 |
|
|
<param name="funder">EC</param>
|
132 |
|
|
<param name="acronym">EXSCALATE4CoV</param>
|
133 |
|
|
</concept>
|
134 |
51882
|
miriam.bag
|
</category>
|
135 |
58312
|
alessia.ba
|
<category claim="false" id="covid-19::subcommunity" label="covid-19 communities"/>
|
136 |
|
|
<category claim="false" id="covid-19::contentproviders" label="covid-19 Content providers">
|
137 |
|
|
<concept claim="false" id="covid-19::contentproviders::1" label="ZENODO">
|
138 |
58278
|
alessia.ba
|
<param name="openaireId">opendoar____::358aee4cc897452c00244351e4d91f69</param>
|
139 |
|
|
<param name="name">ZENODO</param>
|
140 |
|
|
<param name="officialname">ZENODO</param>
|
141 |
|
|
<param name="enabled">true</param>
|
142 |
58300
|
alessia.ba
|
<param name="selcriteria">{"criteria":[{"constraint":[{"verb":"contains","field":"title","value":"COVID-19"}]},
|
143 |
|
|
{"constraint":[{"verb":"contains","field":"title","value":"SARS-CoV-2"}]},
|
144 |
|
|
{"constraint":[{"verb":"contains","field":"title","value":"2019-nCoV"}]}]}
|
145 |
|
|
</param>
|
146 |
58278
|
alessia.ba
|
</concept>
|
147 |
58312
|
alessia.ba
|
<concept claim="false" id="covid-19::contentproviders::2" label="Zenodo">
|
148 |
58278
|
alessia.ba
|
<param name="openaireId">re3data_____::7b0ad08687b2c960d5aeef06f811d5e6</param>
|
149 |
|
|
<param name="name">Research. Shared</param>
|
150 |
|
|
<param name="officialname">Zenodo</param>
|
151 |
|
|
<param name="enabled">true</param>
|
152 |
58300
|
alessia.ba
|
<param name="selcriteria">{"criteria":[{"constraint":[{"verb":"contains","field":"title","value":"COVID-19"}]},
|
153 |
|
|
{"constraint":[{"verb":"contains","field":"title","value":"SARS-CoV-2"}]},
|
154 |
|
|
{"constraint":[{"verb":"contains","field":"title","value":"2019-nCoV"}]}]}
|
155 |
|
|
</param>
|
156 |
58278
|
alessia.ba
|
</concept>
|
157 |
58312
|
alessia.ba
|
<concept claim="false" id="covid-19::contentproviders::3" label="DOAJ-Articles">
|
158 |
58278
|
alessia.ba
|
<param name="openaireId">driver______::bee53aa31dc2cbb538c10c2b65fa5824</param>
|
159 |
|
|
<param name="name">DOAJ-Articles</param>
|
160 |
|
|
<param name="officialname">DOAJ-Articles</param>
|
161 |
|
|
<param name="enabled">true</param>
|
162 |
58300
|
alessia.ba
|
<param name="selcriteria">{"criteria":[{"constraint":[{"verb":"contains","field":"title","value":"COVID-19"}]},
|
163 |
|
|
{"constraint":[{"verb":"contains","field":"title","value":"SARS-CoV-2"}]},
|
164 |
|
|
{"constraint":[{"verb":"contains","field":"title","value":"2019-nCoV"}]}]}
|
165 |
|
|
</param>
|
166 |
58278
|
alessia.ba
|
</concept>
|
167 |
58312
|
alessia.ba
|
<concept claim="false" id="covid-19::contentproviders::4" label="CORE">
|
168 |
58278
|
alessia.ba
|
<param name="openaireId">openaire____::437f4b072b1aa198adcbc35910ff3b98</param>
|
169 |
|
|
<param name="name">CORE</param>
|
170 |
|
|
<param name="officialname">CORE</param>
|
171 |
|
|
<param name="enabled">true</param>
|
172 |
58300
|
alessia.ba
|
<param name="selcriteria">{"criteria":[{"constraint":[{"verb":"contains","field":"title","value":"COVID-19"}]},
|
173 |
|
|
{"constraint":[{"verb":"contains","field":"title","value":"SARS-CoV-2"}]},
|
174 |
|
|
{"constraint":[{"verb":"contains","field":"title","value":"2019-nCoV"}]}]}
|
175 |
|
|
</param>
|
176 |
58278
|
alessia.ba
|
</concept>
|
177 |
58312
|
alessia.ba
|
<concept claim="false" id="covid-19::contentproviders::5" label="Crossref">
|
178 |
58278
|
alessia.ba
|
<param name="openaireId">openaire____::081b82f96300b6a6e3d282bad31cb6e2</param>
|
179 |
|
|
<param name="name">Crossref</param>
|
180 |
|
|
<param name="officialname">Crossref</param>
|
181 |
|
|
<param name="enabled">true</param>
|
182 |
58300
|
alessia.ba
|
<param name="selcriteria">{"criteria":[{"constraint":[{"verb":"contains","field":"title","value":"COVID-19"}]},
|
183 |
|
|
{"constraint":[{"verb":"contains","field":"title","value":"SARS-CoV-2"}]},
|
184 |
|
|
{"constraint":[{"verb":"contains","field":"title","value":"2019-nCoV"}]}]}
|
185 |
|
|
</param>
|
186 |
58278
|
alessia.ba
|
</concept>
|
187 |
58312
|
alessia.ba
|
<concept claim="false" id="covid-19::contentproviders::6" label="Datacite">
|
188 |
58278
|
alessia.ba
|
<param name="openaireId">openaire____::9e3be59865b2c1c335d32dae2fe7b254</param>
|
189 |
|
|
<param name="name">Datacite</param>
|
190 |
|
|
<param name="officialname">Datacite</param>
|
191 |
|
|
<param name="enabled">true</param>
|
192 |
58300
|
alessia.ba
|
<param name="selcriteria">{"criteria":[{"constraint":[{"verb":"contains","field":"title","value":"COVID-19"}]},
|
193 |
|
|
{"constraint":[{"verb":"contains","field":"title","value":"SARS-CoV-2"}]},
|
194 |
|
|
{"constraint":[{"verb":"contains","field":"title","value":"2019-nCoV"}]}]}
|
195 |
|
|
</param>
|
196 |
58278
|
alessia.ba
|
</concept>
|
197 |
58312
|
alessia.ba
|
<concept claim="false" id="covid-19::contentproviders::7" label="Europe PubMed Central">
|
198 |
58278
|
alessia.ba
|
<param name="openaireId">opendoar____::8b6dd7db9af49e67306feb59a8bdc52c</param>
|
199 |
|
|
<param name="name">Europe PubMed Central</param>
|
200 |
|
|
<param name="officialname">Europe PubMed Central</param>
|
201 |
|
|
<param name="enabled">true</param>
|
202 |
58300
|
alessia.ba
|
<param name="selcriteria">{"criteria":[{"constraint":[{"verb":"contains","field":"title","value":"COVID-19"}]},
|
203 |
|
|
{"constraint":[{"verb":"contains","field":"title","value":"SARS-CoV-2"}]},
|
204 |
|
|
{"constraint":[{"verb":"contains","field":"title","value":"2019-nCoV"}]}]}
|
205 |
|
|
</param>
|
206 |
58278
|
alessia.ba
|
</concept>
|
207 |
58312
|
alessia.ba
|
<concept claim="false" id="covid-19::contentproviders::8" label="Preprints.org">
|
208 |
58278
|
alessia.ba
|
<param name="openaireId">share_______::4719356ec8d7d55d3feb384ce879ad6c</param>
|
209 |
|
|
<param name="name">Preprints.org</param>
|
210 |
|
|
<param name="officialname">Preprints.org</param>
|
211 |
|
|
<param name="enabled">true</param>
|
212 |
58300
|
alessia.ba
|
<param name="selcriteria">{"criteria":[{"constraint":[{"verb":"contains","field":"title","value":"COVID-19"}]},
|
213 |
|
|
{"constraint":[{"verb":"contains","field":"title","value":"SARS-CoV-2"}]},
|
214 |
|
|
{"constraint":[{"verb":"contains","field":"title","value":"2019-nCoV"}]}]}
|
215 |
|
|
</param>
|
216 |
58278
|
alessia.ba
|
</concept>
|
217 |
58312
|
alessia.ba
|
<concept claim="false" id="covid-19::contentproviders::9" label="bioRxiv">
|
218 |
58278
|
alessia.ba
|
<param name="openaireId">share_______::bbd802baad85d1fd440f32a7a3a2c2b1</param>
|
219 |
|
|
<param name="name">bioRxiv</param>
|
220 |
|
|
<param name="officialname">bioRxiv</param>
|
221 |
|
|
<param name="enabled">true</param>
|
222 |
58300
|
alessia.ba
|
<param name="selcriteria">{"criteria":[{"constraint":[{"verb":"contains","field":"title","value":"COVID-19"}]},
|
223 |
|
|
{"constraint":[{"verb":"contains","field":"title","value":"SARS-CoV-2"}]},
|
224 |
|
|
{"constraint":[{"verb":"contains","field":"title","value":"2019-nCoV"}]}]}
|
225 |
|
|
</param>
|
226 |
58278
|
alessia.ba
|
</concept>
|
227 |
58312
|
alessia.ba
|
<concept claim="false" id="covid-19::contentproviders::10" label="arXiv.org e-Print Archive">
|
228 |
58278
|
alessia.ba
|
<param name="openaireId">opendoar____::6f4922f45568161a8cdf4ad2299f6d23</param>
|
229 |
|
|
<param name="name">arXiv.org e-Print Archive</param>
|
230 |
|
|
<param name="officialname">arXiv.org e-Print Archive</param>
|
231 |
|
|
<param name="enabled">true</param>
|
232 |
58300
|
alessia.ba
|
<param name="selcriteria">{"criteria":[{"constraint":[{"verb":"contains","field":"title","value":"COVID-19"}]},
|
233 |
|
|
{"constraint":[{"verb":"contains","field":"title","value":"SARS-CoV-2"}]},
|
234 |
|
|
{"constraint":[{"verb":"contains","field":"title","value":"2019-nCoV"}]}]}
|
235 |
|
|
</param>
|
236 |
58278
|
alessia.ba
|
</concept>
|
237 |
58518
|
alessia.ba
|
<concept claim="false" id="covid-19::contentproviders::11" label="ClinicalTrials.gov">
|
238 |
|
|
<param name="openaireId">re3data_____::978378def740bbf2bfb420de868c460b</param>
|
239 |
|
|
<param name="name">ClinicalTrials.gov</param>
|
240 |
|
|
<param name="officialname">ClinicalTrials.gov</param>
|
241 |
|
|
<param name="enabled">true</param>
|
242 |
|
|
<param name="selcriteria">{"criteria":[{"constraint":[{"verb":"contains","field":"title","value":"COVID-19"}]},
|
243 |
|
|
{"constraint":[{"verb":"contains","field":"title","value":"SARS-CoV-2"}]},
|
244 |
|
|
{"constraint":[{"verb":"contains","field":"title","value":"2019-nCoV"}]}]}
|
245 |
|
|
</param>
|
246 |
|
|
</concept>
|
247 |
51882
|
miriam.bag
|
</category>
|
248 |
58312
|
alessia.ba
|
<category claim="false" id="covid-19::zenodocommunities" label="covid-19 Zenodo Communities">
|
249 |
53878
|
miriam.bag
|
</category>
|
250 |
58510
|
alessia.ba
|
<category claim="false" id="covid-19::organizations" label="covid-19 Organizations">
|
251 |
|
|
<concept claim="false" id="covid-19::organizations::1" label="OpenAIRE">
|
252 |
|
|
<param name="name">EuroMarine</param>
|
253 |
|
|
<param name="logourl">aHR0cHM6Ly93d3cuZXVyb21hcmluZW5ldHdvcmsuZXUvc3lzdGVtL2ZpbGVzLzIwMTYvbG9nb19ldXJvbWFyaW5lX3JnYl8zMDBkcGkucG5n</param>
|
254 |
|
|
<param name="websiteurl">aHR0cHM6Ly93d3cuZXVyb21hcmluZW5ldHdvcmsuZXUvc3lzdGVtL2ZpbGVzLzIwMTYvbG9nb19ldXJvbWFyaW5lX3JnYl8zMDBkcGkucG5naHR0cDovL3Rpbnl1cmwuY29tL3k1ZWs0Z2w5</param>
|
255 |
|
|
</concept>
|
256 |
|
|
</category>
|
257 |
51882
|
miriam.bag
|
</context>
|
258 |
|
|
</CONFIGURATION>
|
259 |
|
|
<STATUS/>
|
260 |
|
|
<SECURITY_PARAMETERS/>
|
261 |
|
|
</BODY>
|
262 |
54791
|
alessia.ba
|
</RESOURCE_PROFILE>
|